This is a single-center, single-arm, open-label phase 1/2 study of CART19 in children and young adults with refractory Systemic lupus erythematosus (SLE), incl…

SLESystemic Lupus Erythematosus (SLE)CAR T Cell+4 more

~Estimated

~$10 – $6,250

Children's Hospital of PhiladelphiaNCT06839976

Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products

Subjects exposed to gene therapy products (GTPs) may be at risk for delayed or long-term adverse events. This is a long-term follow-up (LTFU) protocol designed…

CAR T CellCAR T Cell Therapy

~Estimated

~$10 – $750

Seattle Children's HospitalNCT07424157